Strensiq

Active Ingredient(s): Asfotase Alfa
FDA Approved: * October 23, 2015
Pharm Company: * ALEXION PHARM
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Strensiq 18 mg/.45ml Subcutaneous Solution
NDC: 25682-010
Labeler:
Alexion Pharmaceuticals Inc.
Strensiq 28 mg/.7ml Subcutaneous Solution
NDC: 25682-013
Labeler:
Alexion Pharmaceuticals Inc.
Strensiq 40 mg/ml Subcutaneous Solution
NDC: 25682-016
Labeler:
Alexion Pharmaceuticals Inc.
Strensiq 80 mg/.8ml Subcutaneous Solution
NDC: 25682-019
Labeler:
Alexion Pharmaceuticals Inc.